Literature DB >> 26972278

Akt3 knockdown induces mitochondrial dysfunction in human cancer cells.

Minjee Kim1, Young Yeon Kim1, Hye Jin Jee1, Sun Sik Bae2, Na Young Jeong3, Jee-Hyun Um1, Jeanho Yun4.   

Abstract

Akt/PKB plays a pivotal role in cell proliferation and survival. However, the isotype-specific roles of Akt in mitochondrial function have not been fully addressed. In this study, we explored the role of Akt in mitochondrial function after stable knockdown of the Akt isoforms in EJ human bladder cancer cells. We found that the mitochondrial mass was significantly increased in the Akt1- and Akt3-knockdown cells, and this increase was accompanied by an increase in TFAM and NRF1. Akt2 knockdown did not cause a similar effect. Interestingly, Akt3 knockdown also led to severe structural defects in the mitochondria, an increase in doxorubicin-induced senescence, and impairment of cell proliferation in galactose medium. Consistent with these observations, the mitochondrial oxygen consumption rate was significantly reduced in the Akt3-knockdown cells. An Akt3 deficiency-induced decrease in mitochondrial respiration was also observed in A549 lung cancer cells. Collectively, these results suggest that the Akt isoforms play distinct roles in mitochondrial function and that Akt3 is critical for proper mitochondrial respiration in human cancer cells.
© The Author 2016. Published by ABBS Editorial Office in association with Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.

Entities:  

Keywords:  Akt; Akt3; isoform-specific function; mitochondria

Mesh:

Substances:

Year:  2016        PMID: 26972278      PMCID: PMC4888356          DOI: 10.1093/abbs/gmw014

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  34 in total

1.  Melatonin suppresses doxorubicin-induced premature senescence of A549 lung cancer cells by ameliorating mitochondrial dysfunction.

Authors:  Naree Song; Ae Jeong Kim; Hyun-Ju Kim; Hye Jin Jee; Minjee Kim; Young Hyun Yoo; Jeanho Yun
Journal:  J Pineal Res       Date:  2012-04-27       Impact factor: 13.007

Review 2.  Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay.

Authors:  Koji Itahana; Judith Campisi; Goberdhan P Dimri
Journal:  Methods Mol Biol       Date:  2007

Review 3.  Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes, and cancer.

Authors:  Dongchon Kang; Naotaka Hamasaki
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

Review 4.  Signaling specificity in the Akt pathway in biology and disease.

Authors:  Alex Toker; Sandra Marmiroli
Journal:  Adv Biol Regul       Date:  2014-04-19

5.  Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta).

Authors:  H Cho; J Mu; J K Kim; J L Thorvaldsen; Q Chu; E B Crenshaw; K H Kaestner; M S Bartolomei; G I Shulman; M J Birnbaum
Journal:  Science       Date:  2001-06-01       Impact factor: 47.728

6.  Use of the fluorescent dye 10-N-nonyl acridine orange in quantitative and location assays of cardiolipin: a study on different experimental models.

Authors:  Maria Inmaculada Garcia Fernandez; Daniela Ceccarelli; Umberto Muscatello
Journal:  Anal Biochem       Date:  2004-05-15       Impact factor: 3.365

7.  Akt2, but not Akt1, is required for cell survival by inhibiting activation of JNK and p38 after UV irradiation.

Authors:  M-A Kim; H-J Kim; H J Jee; A J Kim; Y-S Bae; S S Bae; J Yun
Journal:  Oncogene       Date:  2009-01-19       Impact factor: 9.867

8.  A family with severe insulin resistance and diabetes due to a mutation in AKT2.

Authors:  Stella George; Justin J Rochford; Christian Wolfrum; Sarah L Gray; Sven Schinner; Jenny C Wilson; Maria A Soos; Peter R Murgatroyd; Rachel M Williams; Carlo L Acerini; David B Dunger; David Barford; A Margot Umpleby; Nicholas J Wareham; Huw Alban Davies; Alan J Schafer; Markus Stoffel; Stephen O'Rahilly; Inês Barroso
Journal:  Science       Date:  2004-05-28       Impact factor: 47.728

Review 9.  Mutations causing mitochondrial disease: What is new and what challenges remain?

Authors:  Robert N Lightowlers; Robert W Taylor; Doug M Turnbull
Journal:  Science       Date:  2015-09-24       Impact factor: 47.728

Review 10.  Mitochondrial disorders.

Authors:  Massimo Zeviani; Valerio Carelli
Journal:  Curr Opin Neurol       Date:  2003-10       Impact factor: 5.710

View more
  7 in total

1.  Repression of Akt3 gene transcription by the tumor suppressor RIZ1.

Authors:  Qingnan Liu; Xiaotian Qu; Xiaolei Xie; Pei He; Shi Huang
Journal:  Sci Rep       Date:  2018-01-24       Impact factor: 4.379

2.  MicroRNA-16 functions as a tumor-suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2.

Authors:  Xi Wang; Guang-Hui Li
Journal:  J Cell Physiol       Date:  2018-08-22       Impact factor: 6.384

3.  Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.

Authors:  Yaowei Li; Li Li
Journal:  J Ovarian Res       Date:  2019-11-08       Impact factor: 4.234

4.  High Expression MicroRNA-206 Inhibits the Growth of Tumor Cells in Human Malignant Fibrous Histiocytoma.

Authors:  Dejian Li; Kai Zhao; Ziwen Zhao; Bo Jiang; Xianxu Gong; Yan Zhang; Yingqi Guo; Han Xiao; Ye Wang; Hui Liu; Chengqing Yi; Wenguang Gu
Journal:  Front Cell Dev Biol       Date:  2021-11-25

5.  The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients.

Authors:  Zicheng Wang; Jiayi Li; Peizhi Zhang; Leizuo Zhao; Bingyin Huang; Yingkun Xu; Guangzhen Wu; Qinghua Xia
Journal:  Front Genet       Date:  2022-07-12       Impact factor: 4.772

6.  The tumor suppressor role of microRNA-338-3p in renal cell carcinoma.

Authors:  Yidong Huang; Yang Wu; Li Zeng; Wei Shan; Lugang Huang
Journal:  Oncol Lett       Date:  2018-06-06       Impact factor: 2.967

7.  PDE5 inhibition rescues mitochondrial dysfunction and angiogenic responses induced by Akt3 inhibition by promotion of PRC expression.

Authors:  Daniel G Corum; Dorea P Jenkins; James A Heslop; Lacey M Tallent; Gyda C Beeson; Jeremy L Barth; Rick G Schnellmann; Robin C Muise-Helmericks
Journal:  J Biol Chem       Date:  2020-10-21       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.